Vigil Neuroscience, Inc. operates as a biotechnology company. The Company focuses on discovering and developing novel therapeutics in basic science and human genetics of microglia. Vigil Neuroscience serves customers in the United States.

Current Report (Form 8-K | Period ending 2024-06-27)

Current Report (Form 8-K | Period ending 2024-06-05)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Vigil Neuroscience (VIGL US)

Current Report (Form 8-K | Period ending 2024-06-27)

Current Report (Form 8-K | Period ending 2024-06-05)

Current Report (Form 8-K | Period ending 2024-05-07)

Quarterly Report (Form 10-Q | Period ending 2024-03-31)

Annual Report to Security Holders (Form ARS | Period ending 2023-12-31)

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)